BFS
BMRN icon

Bare Financial Services’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bare Financial Services’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.44K Buy
165
+69
+72% +$3.78K ﹤0.01% 602
2026
Q1 		$5.42K Buy
96
+81
+540% +$4.72K ﹤0.01% 612
2025
Q4 		$891 Sell
15
-15
-50% -$817 ﹤0.01% 1178
2025
Q3 		$1.63K Sell
30
-28
-48% -$1.6K ﹤0.01% 870
2025
Q2 		$3.19K Buy
58
+55
+1,833% +$3.24K ﹤0.01% 660
2025
Q1 		$212 Buy
+3
New +$202 ﹤0.01% 931

Other funds holding BMRN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Bare Financial Services's BMRN Position: Q2 2026 in Review

Bare Financial Services increased its BioMarin Pharmaceuticals (BMRN) stake by 72% in Q2 2026, buying an estimated $3.78K and bringing the position to 165 shares worth $9.44K. The position accounts for ﹤0.01% of the portfolio, ranked #602.

Bare Financial Services first reported a position in BMRN in Q1 2025 and has held it in 6 quarters since. 565 funds tracked by Wall St. Rank hold BMRN as of Q2 2026.

  • Bare Financial Services held 165 shares of BioMarin Pharmaceuticals worth $9.44K as of Q2 2026.
  • Bare Financial Services bought 69 BioMarin Pharmaceuticals shares in Q2 2026, an estimated $3.78K.
  • BioMarin Pharmaceuticals made up ﹤0.01% of Bare Financial Services's portfolio in Q2 2026, its #602 holding.
  • Bare Financial Services first reported a position in BioMarin Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
  • 565 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q2 2026.

Based on Bare Financial Services's 13F filing for Q2 2026, filed 27 Jul 2026.